DanaP.AlbonMD

PubMed

• Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants.
  Emily Mitchell, Dana Albon> ;Pediatric Pulmonology. 2024 Apr 12
• Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality imp...
  List, R., Bichl, S., Horton, B., Shen, S., Corcoran, B., Sadeghi, H., Britto, M., , Solomon, G., Ren, C., Albon, D.> ;BMJ Open Quality. 2023 Dec 28
• Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis.
  Lonabaugh, K. P., Kevin Lonabaugh, Galvin Li, Rhonda List, Reyna Huang, Amber James, Andrew Barros, Lindsay Somerville, Dana Albon> ;Pharmacotherapy. 2024 Mar 1
• Analysis of iron status after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis.
  Lonabaugh, K. P., Amber James, Galvin Li, Rhonda List, Kevin Lonabaugh, Aaron D Smith, Andrew Barros, Lindsay Somerville, Dana Albon> ;Pediatric Pulmonology. 2024 Mar 1
• 5 citations
  Establishing a Cystic Fibrosis Learning Network: Interventions to promote collaboration and data-driven improvement at scale.
  Thida Ong, Dana Albon, Raouf S Amin, Julianna Bailey, Srujana Bandla, Maria T Britto, Jonathan Flath, Breck Gamel, Michael Powers, Kathryn A Sabadosa, Anna K Saulitis,...> ;Learning Health Systems. 2023 Jul 1
• The Impact of CFTR Modulator Triple Therapy on Type 2 Inflammatory Response in Patients with Cystic Fibrosis.
  Ajay Mehta, Irene Lee, Galvin Li, Marieke Jones, Lydia Hanson, Kevin Lonabaugh, Rhonda List, Larry Borish, Dana Albon> ;Research Square. 2023 May 10
• 2 citations
  Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization.
  Dana Albon, Lijia Zhang, James Patrie, Marieke Jones, Z Galvin Li, Emily Noonan, Larry Borish> ;Allergy, Asthma, and Clinical Immunology. 2023 Feb 27
• 18 citations
  Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis.
  Lijia Zhang, Dana Albon, Marieke Jones, Heather Bruschwein> ;Therapeutic Advances in Respiratory Disease. 2022 Dec 23
• 2 citations
  Factors associated with receiving CF care and use of telehealth in 2020 among persons with Cystic Fibrosis in the United States.
  J M Collaco, D Albon, J S Ostrenga, P Flume, M S Schechter, E A Cromwell> ;Journal of Cystic Fibrosis. 2023 May 1
• 3 citations
  3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects.
  Steven Guan, Nick Tustison, Kun Qing, Yun Michael Shim, John Mugler 3rd, Talissa Altes, Dana Albon, Deborah Froh, Borna Mehrad, James Patrie, Alan Ropp, Braden Miller,...> ;Tomography. 2022 Oct 13
• 3 citations
  Social determinants of health screening and intervention: A cystic fibrosis quality improvement process.
  Deirdre Jennings, Rhonda List, Heather Bruschwein, Martina Compton, Lindsay Somerville, Lauren Williamson, Rachel Murray, Brielle Evangelista, Dana Albon> ;Pediatric Pulmonology. 2022 Dec 1
• A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.
  Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA, STOP2 Investigators> ;American journal of respiratory and critical care medicine.
• 7 citations
  Cystic fibrosis learning network telehealth innovation lab during the COVID-19 pandemic: a success QI story for interdisciplinary care and agenda setting.
  Dana Albon, Lacrecia Thomas, Lindsay Hoberg, Sophia Stamper, Lindsay Somerville, Prigi Varghese, Ella Balasa, Matthew Roman, Maria T Britto, Melanie Miner, Emily Gehri...> ;BMJ Open Quality. 2022 May 1
• 4 citations
  Mental health screening of patients with cystic fibrosis through telehealth during COVID-19: Evaluation of feasibility and process adoption.
  Heather M Bruschwein, Morgan Soper, Deirdre Jennings, Rhonda List, Martina H Compton, Rachel Turner, Dana Albon, Somerville, L.> ;Families, Systems & Health. 2022 Sep 1
• 18 citations
  Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.
  Adam J Kimple, Brent A Senior, Edward T Naureckas, David A Gudis, Ted Meyer, Sarah E Hempstead, Helaine E Resnick, Dana Albon, Wayne Barfield, Margo McKenna Benoit, Da...> ;International Forum of Allergy & Rhinology. 2022 Sep 1
• 9 citations
  Real-World Outcomes in Cystic Fibrosis Telemedicine Clinical Care in a Time of a Global Pandemic.
  Lindsay A L Somerville, Rhonda P List, Martina H Compton, Heather M Bruschwein, Deirdre Jennings, Marieke K Jones, Rachel K Murray, Elissa R Starheim, Katherine M Webb...> ;Chest. 2022 May 1
• 23 citations
  Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors.
  Dana Albon, Aricca D Van Citters, Thida Ong, Olivia Dieni, Christopher Dowd, Anne Willis, Kathryn A Sabadosa, Peter Scalia, Kimberly Reno, Gabriela R Oates, Michael S ...> ;Journal of Cystic Fibrosis. 2021 Dec 1
• 6 citations
  Impact of COVID-19 on social determinants of health for adults with cystic fibrosis.
  Dana Albon, Heather Bruschwein, Morgan Soper, Rhonda List, Deirdre Jennings, Lucy S Gettle, Martina Compton, Molly Bailey, Elissa Starheim, Rachel Murray, John Kalmane...> ;Therapeutic Advances in Respiratory Disease. 2021 Aug 21
• 12 citations
  Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: a quality improvement process.
  M. Compton, R. List, E. Starheim, L. Somerville, Lauren Williamson, Rachel Murray, Deirdre Jennings, Heather Bruschwein, D. Albon> ;BMJ Open Quality. 2021 Aug 1
• 10 citations
  Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria
  Herman O.I. Pfaeffle, Reem M. Alameer, Mary H. Marshall, Eric R. Houpt, D. Albon, Scott K. Heysell> ;Pulmonary Pharmacology & Therapeutics. 2021 Oct 1
• 17 citations
  Preserving Multidisciplinary Care Model and Patient Safety During Reopening of Ambulatory Cystic Fibrosis Clinic for Nonurgent Care: A Hybrid Telehealth Model.
  R. List, M. Compton, Morgan Soper, Heather Bruschwein, L. Gettle, Molly Bailey, E. Starheim, John Kalmanek, L. Somerville, D. Albon> ;Telemedicine Journal and e-Health. 2021 Feb 11
• 19 citations
  Potential Implications of the COVID-19 Pandemic on the Homeless Population.
  D. Albon, Morgan Soper, Anthony Haro> ;Chest. 2020 Apr 10
• 48 citations
  A Feasibility Study of Urgent Implementation of Cystic Fibrosis Multidisciplinary Telemedicine Clinic in the Face of COVID-19 Pandemic: Single-Center Experience.
  M. Compton, Morgan Soper, Bonnie Reilly, L. Gettle, R. List, Molly Bailey, Heather Bruschwein, L. Somerville, D. Albon> ;Telemedicine Journal and e-Health. 2020 Aug 4
• 6 citations
  Prevalence and Risk Factors for Iron Deficiency in Adults With Cystic Fibrosis.
  Lucy S Gettle, Adrienne Harden, Meagan Bridges, Dana Albon> ;Nutrition in Clinical Practice. 2020 Jan 29
• 15 citations
  Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series
  Lijia Zhang, Larry Borish, Anna R. Smith, L. Somerville, D. Albon> ;Allergy, Asthma, and Clinical Immunology. 2020 Jan 6
• Join now to see all